FDA Calls for Nominations of Difficult to Compound Drugs

The U.S. Food and Drug Administration (FDA) is required by statute to maintain a list of drug products that cannot be manufactured by pharmaceutical compounding because they are demonstrably difficult to compound. In a notification released on Wednesday, 4 December, the FDA announced that it is accepting nominations for drug products to include on the list. In order to be considered for the inaugural list, nominations must be received by 4 March 2014.

Read More: FDA Calls for Nominations of Difficult to Compound Drugs


Download PDF Share Back To Listing
Loading data